The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anil Champalal Jain

Ownership Changes View source PDF Explain this filing

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹312.80

prior close

₹305.35

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%-0.3% vs market

Pharmaceuticals peers, median of 156sector-1.8%-1.3% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.4

15m

-0.5

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-2.8-0.3-1.8-1.3

Next day

-0.9-2.0+1.1-1.0+0.1

-3.3-6.5+3.2-4.9+1.5

-2.2-3.8+1.6-3.2+1.0

-0.8-1.5+0.7-1.9+1.1

-4.5-4.3-0.2-4.3-0.2

-1.2-2.8+1.6-3.6+2.4

15d

+13.7+8.2+5.6+6.9+6.8

+6.1+10.1-4.0+6.7-0.6

-7.0+12.4-19.4+9.5-16.5

+0.9+23.5-22.6+13.9-13.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has received a disclosure from Anil Champalal Jain (a promoter of Bajaj Healthcare) under Regulation 29(1) of the SEBI Takeover Regulations, which deals with reporting acquisitions or disposals of shares that cross prescribed thresholds. The actual filing details — number of shares traded, transaction price, and pre- and post-holding percentages — are not available in the document provided. The BSE page linked was a 404/error page, so no transaction-level data could be retrieved.

Likely market impact

Without the specific buy/sell quantity and resulting shareholding numbers, the impact on shareholders or the stock cannot be determined. Investors should check the full SAST disclosure on BSE/NSE to see whether the promoter has increased, decreased, or crossed any shareholding threshold.